![TransCode Therapeutics Inc](/common/images/company/N_RNAZ.png)
TransCode Therapeutics Inc is an RNA oncology company. It is created to defeat the cancer through the intelligent design and effective delivery of RNA therapeutics. The company's lead therapeutic candidate, TTX-MC138, is focused on treating metastatic cancer, which has the potential to produce regre... TransCode Therapeutics Inc is an RNA oncology company. It is created to defeat the cancer through the intelligent design and effective delivery of RNA therapeutics. The company's lead therapeutic candidate, TTX-MC138, is focused on treating metastatic cancer, which has the potential to produce regression without recurrence in a range of cancers, including breast, pancreatic, ovarian and colon cancer, glioblastomas and others. Show more
BOSTON, July 22, 2024 (GLOBE NEWSWIRE) -- TransCode Therapeutics, Inc. (Nasdaq: RNAZ) (โTransCodeโ or the โCompanyโ), a clinical-stage RNA oncology company committed to more effectively treating...
BOSTON, June 10, 2024 (GLOBE NEWSWIRE) -- TransCode Therapeutics, Inc. (Nasdaq: RNAZ), (the โCompanyโ), an RNA oncology company committed to more effectively treating cancer using RNA...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | -0.407 | -47.4912485414 | 0.857 | 0.98 | 0.781 | 112350 | 0.9280493 | CS |
4 | -0.55 | -55 | 1 | 1.12 | 0.64 | 192298 | 0.87836048 | CS |
12 | -0.0989 | -18.0178538896 | 0.5489 | 2.01 | 0.4222 | 1323082 | 1.10292028 | CS |
26 | -0.36 | -44.4444444444 | 0.81 | 2.01 | 0.42 | 923730 | 0.95124147 | CS |
52 | -99.15 | -99.5481927711 | 99.6 | 128 | 0.42 | 2517099 | 26.29843647 | CS |
156 | -2639.55 | -99.9829545455 | 2640 | 4222.88 | 0.42 | 1653135 | 841.19332118 | CS |
260 | -4799.55 | -99.990625 | 4800 | 5600 | 0.42 | 1688696 | 946.38672678 | CS |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.